Form 8-K - Current report:
SEC Accession No. 0001193125-24-285936
Filing Date
2024-12-27
Accepted
2024-12-27 16:16:29
Documents
13
Period of Report
2024-12-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d903966d8k.htm   iXBRL 8-K 24296
  Complete submission text file 0001193125-24-285936.txt   146287

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iobt-20241226.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20241226_lab.xml EX-101.LAB 17911
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20241226_pre.xml EX-101.PRE 11239
15 EXTRACTED XBRL INSTANCE DOCUMENT d903966d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241585914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)